A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of dexmedetomidine in ICU
subjects who are initially intubated, mechanically ventilated and require sedation for beyond
24 hours.
Phase:
Phase 4
Details
Lead Sponsor:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer